Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies
about
Chronic alcohol abuse and HIV disease progression: studies with the non-human primate modelUsing nonhuman primates to model HIV transmissionTracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmissionA New Method for Rapid Screening of End-Point PCR Products: Application to Single Genome Amplified HIV and SIV Envelope AmpliconsSurvivors Remorse: antibody-mediated protection against HIV-1.Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primatesNew directions for HIV vaccine development from animal models.Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys.NK cell responses to simian immunodeficiency virus vaginal exposure in naive and vaccinated rhesus macaquesMolecularly tagged simian immunodeficiency virus SIVmac239 synthetic swarm for tracking independent infection eventsRapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window.Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection.Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV InfectionMolecular determinants of the ratio of inert to infectious virus particles.Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques.Enhanced antagonism of BST-2 by a neurovirulent SIV envelopeEnvelope residue 375 substitutions in simian-human immunodeficiency viruses enhance CD4 binding and replication in rhesus macaquesCD4+ T cells support production of simian immunodeficiency virus Env antibodies that enforce CD4-dependent entry and shape tropism in vivo.Mapping the complete glycoproteome of virion-derived HIV-1 gp120 provides insights into broadly neutralizing antibody binding.Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection.Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 AcquisitionVaccination with Vaxfectin(®) adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia.Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.Virion Background and Efficiency of Virion Incorporation Determine Susceptibility of Simian Immunodeficiency Virus Env-Driven Viral Entry to Inhibition by IFITM Proteins.Rare Control of SIVmac239 Infection in a Vaccinated Rhesus Macaque.A penalized regression approach to haplotype reconstruction of viral populations arising in early HIV/SIV infection.Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.Nonhuman primate models for the evaluation of HIV-1 preventive vaccine strategies: model parameter considerations and consequences.Identification and characterization of a macrophage-tropic SIV envelope glycoprotein variant in blood from early infection in SIVmac251-infected macaques.Vector order determines protection against pathogenic simian immunodeficiency virus infection in a triple component vaccine by balancing CD4+ and CD8+ T-cell responses.Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques.High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses.Persistence of SIV in the brain of SIV-infected Chinese rhesus macaques with or without antiretroviral therapy.In vivo characterization of macrophage-tropic simian immunodeficiency virus molecular clones in rhesus macaques.Control of Heterologous Simian Immunodeficiency Virus SIV Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
P2860
Q26852432-FB71F70E-D5E9-4711-BB8C-68A30E3598D3Q26861425-4620ED09-6DDE-46BE-B82D-ACBB0AF1EFEDQ27313356-2E801BEC-3316-47DA-963A-78DBBA70C531Q28548014-935FD02B-8253-4DA9-83F4-ACC6560C672AQ30238730-CF291210-3BB8-479F-AA3E-7E55FD2913E1Q33355730-D257793B-ABF5-42D2-8136-9577280D32DDQ33767191-B7D170D2-1899-48EE-8A9D-B8057CD07FCDQ33780980-74B0C451-0E0B-4EAF-8A7D-4A2F4C4289DCQ33851763-CFEDCE4E-BED9-415D-BC27-7810E232D3CFQ33900353-04FC4ED9-7028-4032-B586-40B0CB57CAF5Q34108798-643D58CE-B315-44E1-84FB-D9D42099D4B6Q34596417-14769B63-0C98-4EA6-95C8-64A07013DB84Q35156935-38B2D9EF-D336-4DFA-B3CA-52190439E19BQ35494155-AC89A573-B121-43A6-964F-DD6778F8BD9AQ36222317-EE05BA60-08BB-4A2D-BFE4-40245738B92FQ36494676-1609BDB6-C900-471A-8C07-42FE1629DBEAQ36826452-83F4B547-7723-4D42-88F4-557228BB4693Q36951741-1FF5CC6A-ED59-4B95-B3BF-4B4E3863AA0CQ37021717-C5BB2FB8-1F47-4267-B6E8-37E4B603CB2CQ37123579-A87873A9-4DD0-486E-8914-09A834709A37Q37240035-9098B76D-0005-435D-B27C-617B6652BF70Q37252894-13AD2A16-6129-4797-9351-DC2B137FC9B7Q37261545-556702BA-9282-4D45-B285-EB9DF9AC7A6AQ37530461-1DAC23DE-01D3-4E16-B704-7008337ADEBCQ37530466-48A893EA-4E0E-4644-979C-06395461C11EQ38733780-64FFEAE8-A43A-4DF6-8986-E0DB3E9CD74CQ38786450-B05B8624-DCDF-41E4-BB89-15676DB9EBFEQ38853281-6BA6DA03-39DE-4A11-A4F7-65FD09E59B47Q38860309-F3E61661-A02A-42A4-A164-027FC1580FFFQ38936872-D1ED9C3A-F6E2-439C-B904-F22F4F6B2EF5Q39615794-8EE905B2-7FA9-4C80-83F3-3131659740C5Q40042419-DDCFF804-1B52-4791-B527-2BC1AD15C51CQ40106524-3EADD527-4C5A-43EB-843C-EB0D5C242877Q40113278-7DCB55CF-C822-45DC-BAD0-13B3E634EF99Q47552258-974F0D14-3AF2-47BE-A2CD-AD0ED3449B35Q47569998-B58EAD93-511E-443A-9D66-8647E34E1505Q52623429-4D2A5706-A3A9-4149-8190-9A1A203CA00DQ56517308-B073C89F-16D2-4167-8814-0510BF9878F0
P2860
Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Comparative characterization o ...... vivo nonhuman primate studies
@ast
Comparative characterization o ...... vivo nonhuman primate studies
@en
type
label
Comparative characterization o ...... vivo nonhuman primate studies
@ast
Comparative characterization o ...... vivo nonhuman primate studies
@en
prefLabel
Comparative characterization o ...... vivo nonhuman primate studies
@ast
Comparative characterization o ...... vivo nonhuman primate studies
@en
P2093
P2860
P50
P356
P1433
P1476
Comparative characterization o ...... vivo nonhuman primate studies
@en
P2093
Carolyn Reid
Christopher J Miller
Elena Chertova
Gregory Q Del Prete
James D Roser
Jeffrey D Lifson
Kelli Oswald
Laura M Parodi
Laura Newman
Luis D Giavedoni
P2860
P304
P356
10.1128/JVI.03507-12
P407
P577
2013-02-13T00:00:00Z